Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-up
NCT ID: NCT01255982
Last Updated: 2012-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
249 participants
OBSERVATIONAL
2011-03-31
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Diagnosed with bipolar I or II disorder, and with an acute episode of bipolar depression at inclusion
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute depressive episode at inclusion
Exclusion Criteria
* Patients participating or having participated within previous 6 months, in clinical trials
* Mental retardation or any other medical condition affecting cognitive performance
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Elche, Alicante, Spain
Research Site
Villajoyosa, Alicante, Spain
Research Site
Almería, Almería, Spain
Research Site
Barcelona, Barcelona, Spain
Research Site
Granollers, Barcelona, Spain
Research Site
San Boit de LLobregat, Barcelona, Spain
Research Site
Córdoba, Cordoba, Spain
Research Site
Granada, Granada, Spain
Research Site
Lleida, Lerida, Spain
Research Site
Monforte de Lemos, Lugo, Spain
Research Site
Madrid, Madrid, Spain
Research Site
Málaga, Malaga, Spain
Research Site
Tudela, Navarre, Spain
Research Site
Ourense, Orense, Spain
Research Site
Palencia, Palencia, Spain
Research Site
Palma de Mallorca, Palma de Mallorca, Spain
Research Site
Mos, Pontevedra, Spain
Research Site
Langreo, Principality of Asturias, Spain
Research Site
Seville, Sevilla, Spain
Research Site
Tarragona, Tarragona, Spain
Research Site
Catarroja, Valencia, Spain
Research Site
Valencia, Valencia, Spain
Research Site
Zamora, Zamora, Spain
Research Site
Zaragoza, Zaragoza, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NES-DUM-2010/1
Identifier Type: -
Identifier Source: org_study_id